Also known as Welchol
Colesevelam is a bile acid sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.Source: Wikipedia
Estimated Total Cost: $158.51 for an average of 28 days supply
Patients are most commonly prescribed colesevelam to treat hyperlipidemia, ischemic heart disease, acute kidney injury, and blastomycosis.